like drugs with poor heart health outcomes
A study of 80,000 Italian patients suggests that stopping GLP-1 medications like Ozempic may be linked to an increased risk of heart attack, stroke, or death. However, experts caution that the study does not prove causation and lacks data on why patients discontinued the treatment.
Why it matters
As GLP-1 drugs become widely used for diabetes and weight loss, understanding the long-term risks of discontinuation is critical for patient safety and clinical guidance.
Researchers say we do not have enough long-term data about GLP-1 medications. ( Getty Images: brizmaker )
A large study suggests people with type 2 diabetes who start and then stop GLP-1 drugs may have poorer health outcomes.
But Australian experts say more information is needed to support this conclusion.
The study highlights the importance for people taking these medications to work closely with their doctor, experts say, especially if wanting to ease off the drugs.
Link copied Share Share article People with type 2 diabetes who start and then stop using GLP-1 medications may face an increased risk of heart attack, stroke or death than those who keep using them, according to a new international study.
But Australian experts urge caution interpreting the findings, with the study unable to prove causation and no data collected about why people stopped using the drug.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in